Cargando…

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases

BACKGROUND: In vivo assessment of neuroinflammation by 18-kDa translocator protein positron-emission-tomography (TSPO-PET) ligands receives growing interest in preclinical and clinical research of neurodegenerative disorders. Higher TSPO-PET binding as a surrogate for microglial activation in female...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biechele, Gloria, Franzmeier, Nicolai, Blume, Tanja, Ewers, Michael, Luque, Jose Medina, Eckenweber, Florian, Sacher, Christian, Beyer, Leonie, Ruch-Rubinstein, Francois, Lindner, Simon, Gildehaus, Franz-Josef, von Ungern-Sternberg, Barbara, Cumming, Paul, Bartenstein, Peter, Rominger, Axel, Höglinger, Günter U., Herms, Jochen, Brendel, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737385/ https://www.ncbi.nlm.nih.gov/pubmed/33317543 http://dx.doi.org/10.1186/s12974-020-02046-2

Ejemplares similares

Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
por: Blume, Tanja, et al.
Publicado: (2022)

Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
por: Biechele, Gloria, et al.
Publicado: (2022)

Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation
por: Biechele, Gloria, et al.
Publicado: (2021)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
por: Blume, Tanja, et al.
Publicado: (2018)

Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
por: Brendel, Matthias, et al.
Publicado: (2017)

Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
por: Kunze, Lea Helena, et al.
Publicado: (2023)

Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings
por: Völter, Friederike, et al.
Publicado: (2022)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
por: Ewers, Michael, et al.
Publicado: (2020)

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation
por: Brendel, Matthias, et al.
Publicado: (2018)

Cross-Sectional Comparison of Small Animal [(18)F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
por: Brendel, Matthias, et al.
Publicado: (2015)

Comparison of (18)F-T807 and (18)F-THK5117 PET in a Mouse Model of Tau Pathology
por: Brendel, Matthias, et al.
Publicado: (2018)

Data on specificity of [(18)F]GE180 uptake for TSPO expression in rodent brain and myocardium
por: Deussing, Maximilian, et al.
Publicado: (2018)

Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome
por: Schmitt, Julia, et al.
Publicado: (2021)

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment
por: Brendel, M, et al.
Publicado: (2015)

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
por: Brendel, Matthias, et al.
Publicado: (2019)

[(18)F]MPPF and [(18)F]FDG μPET imaging in rats: impact of transport and restraint stress
por: Buchecker, Verena, et al.
Publicado: (2020)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Depletion and activation of microglia impact metabolic connectivity of the mouse brain
por: Gnörich, Johannes, et al.
Publicado: (2023)

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
por: Overhoff, Felix, et al.
Publicado: (2016)

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
por: Neitzel, Julia, et al.
Publicado: (2021)

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects()()
por: Ewers, Michael, et al.
Publicado: (2013)

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
por: Franzmeier, Nicolai, et al.
Publicado: (2019)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging
por: Palumbo, Giovanna, et al.
Publicado: (2023)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

Impact of TSPO Receptor Polymorphism on [(18)F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA
por: Brendel, Matthias, et al.
Publicado: (2020)

Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [(18)F]UCB-H PET imaging
por: Vogler, Letizia, et al.
Publicado: (2023)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
por: Schönecker, Sonja, et al.
Publicado: (2019)

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease
por: Beyer, Leonie, et al.
Publicado: (2019)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
por: Biel, Davina, et al.
Publicado: (2023)

Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study
por: Beyer, Leonie, et al.
Publicado: (2020)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
por: Holzgreve, Adrien, et al.
Publicado: (2016)

Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination
por: Hochstrasser, Tanja, et al.
Publicado: (2019)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
por: Biel, Davina, et al.
Publicado: (2021)

Biodistribution and dosimetry for combined [(177)Lu]Lu-PSMA-I&T/[(225)Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
por: Delker, Astrid, et al.
Publicado: (2023)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j8gn0t4i1o1s7350ebdhjbn25c